Skip Content
You are currently on the new version of our website. Access the old version .

421 Results Found

  • Article
  • Open Access
16 Citations
9,349 Views
17 Pages

23 January 2019

Antidepressant-related sexual dysfunction is a frequent adverse event caused by serotonergic activation that intensely affects quality of life and adherence in depressed patients. The dopamine system has multiple effects promoting sexual behavior, bu...

  • Review
  • Open Access
97 Citations
9,550 Views
20 Pages

Diabetes and Cognitive Impairment: A Role for Glucotoxicity and Dopaminergic Dysfunction

  • Francesca Chiara Pignalosa,
  • Antonella Desiderio,
  • Paola Mirra,
  • Cecilia Nigro,
  • Giuseppe Perruolo,
  • Luca Ulianich,
  • Pietro Formisano,
  • Francesco Beguinot,
  • Claudia Miele and
  • Francesca Fiory
  • + 1 author

16 November 2021

Diabetes mellitus (DM) is a chronic metabolic disorder characterized by hyperglycemia, responsible for the onset of several long-term complications. Recent evidence suggests that cognitive dysfunction represents an emerging complication of DM, but th...

  • Review
  • Open Access
46 Citations
10,495 Views
12 Pages

Parkinson’s disease (PD) is a common neurodegenerative movement disorder that is characterized pathologically by a progressive loss of midbrain dopaminergic neurons and by protein inclusions, designated Lewy bodies and Lewy neurites. PD is one of the...

  • Article
  • Open Access
219 Views
19 Pages

Speech Impairment in Early Parkinson’s Disease Is Associated with Nigrostriatal Dopaminergic Dysfunction

  • Sotirios Polychronis,
  • Grigorios Nasios,
  • Efthimios Dardiotis,
  • Rayo Akande and
  • Gennaro Pagano

27 January 2026

Background/Objectives: Speech difficulties are an early and disabling manifestation of Parkinson’s disease (PD), affecting communication and quality of life. This study aimed to examine demographic, clinical, dopaminergic imaging and cerebrospi...

  • Article
  • Open Access
1 Citations
1,413 Views
24 Pages

Olfactory Dysfunction in a Novel Model of Prodromal Parkinson’s Disease in Adult Zebrafish

  • Nathaniel W. Vorhees,
  • Samantha L. Groenwold,
  • Mackenzie T. Williams,
  • Lexus S. Putt,
  • Nereyda Sanchez-Gama,
  • Grace A. Stalions,
  • Gabriella M. Taylor,
  • Heather E. Van Dort and
  • Erika Calvo-Ochoa

Olfactory dysfunction is a clinical marker of prodromal Parkinson’s disease (PD), yet the underlying mechanisms remain unclear. To explore this relationship, we developed a zebrafish model that recapitulates the olfactory impairment observed in...

  • Article
  • Open Access
6 Citations
5,697 Views
34 Pages

Depletion of Retinal Dopaminergic Activity in a Mouse Model of Rod Dysfunction Exacerbates Experimental Autoimmune Uveoretinitis: A Role for the Gateway Reflex

  • Andrea Stofkova,
  • Miloslav Zloh,
  • Dominika Andreanska,
  • Ivana Fiserova,
  • Jan Kubovciak,
  • Jan Hejda,
  • Patrik Kutilek and
  • Masaaki Murakami

31 December 2021

The gateway reflex is a mechanism by which neural inputs regulate chemokine expression at endothelial cell barriers, thereby establishing gateways for the invasion of autoreactive T cells into barrier-protected tissues. In this study, we hypothesized...

  • Review
  • Open Access
967 Views
22 Pages

12 December 2025

Parkinson’s disease (PD) is a neurodegenerative disorder due to damage of the nigrostriatal pathway and consequent dopamine (DA) deficiency. The main classic symptoms are those related to motor disturbances, such as postural instability, restin...

  • Systematic Review
  • Open Access
2,118 Views
18 Pages

Bromocriptine, Selegiline and Amantadine in the Treatment of Depression—A Systematic Review

  • Rafał Bieś,
  • Marek Krzystanek,
  • Michał Górski,
  • Agnieszka Koźmin-Burzyńska,
  • Anna Warchala,
  • Beata Trędzbor,
  • Ewa Martyniak and
  • Joanna Fojcik

3 November 2025

Background: Depressive disorders are among the most common and disabling psychiatric conditions. A growing body of evidence suggests that dopaminergic dysfunction plays a key role in the pathophysiology of anhedonia, amotivation, and psychomotor slow...

  • Article
  • Open Access
49 Citations
6,108 Views
13 Pages

28 October 2019

α-Synuclein is an abundant neuronal protein that accumulates in insoluble inclusions in Parkinson′s disease and other synucleinopathies. Fatty acids partially regulate α-Synuclein accumulation, and mesencephalic dopaminergic neurons...

  • Review
  • Open Access
7 Citations
8,785 Views
19 Pages

19 October 2022

Parkinson’s disease (PD) is a neurodegenerative movement disorder characterized by the loss of dopaminergic neurons, which results in motor impairment. The rationale and objective of the review article is to determine whether CCBs use contribut...

  • Article
  • Open Access
23 Citations
5,696 Views
16 Pages

Protective Effects of Ferulic Acid against Chronic Cerebral Hypoperfusion-Induced Swallowing Dysfunction in Rats

  • Takashi Asano,
  • Hirokazu Matsuzaki,
  • Naohiro Iwata,
  • Meiyan Xuan,
  • Shinya Kamiuchi,
  • Yasuhide Hibino,
  • Takeshi Sakamoto and
  • Mari Okazaki

Ferulic acid (FA), a phenolic phytochemical, has been reported to exert antioxidative and neuroprotective effects. In this study, we investigated the protective effects of FA against the dysfunction of the swallowing reflex induced by ligation of bil...

  • Article
  • Open Access
34 Citations
5,801 Views
19 Pages

21 February 2022

Parkinson’s disease (PD) is characterized by loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) of the midbrain. Restoration of nigrostriatal dopamine neurons has been proposed as a potential therapeutic strategy for PD....

  • Article
  • Open Access
16 Citations
9,471 Views
13 Pages

13 November 2017

Many studies have shown that the pollutant simazine (6-chloro-N,N′-diethyl-1,3,5-triazine-2,4-diamine), which has been overused, inhibits the proliferation of mammalian dopaminergic cells, and affects the developmental differentiation of mammalian do...

  • Article
  • Open Access
23 Citations
6,285 Views
16 Pages

Pathophysiology of Swallowing Dysfunction in Parkinson Disease and Lack of Dopaminergic Impact on the Swallow Function and on the Effect of Thickening Agents

  • Weslania Viviane Nascimento,
  • Viridiana Arreola,
  • Pilar Sanz,
  • Ediz Necati,
  • Mireia Bolivar-Prados,
  • Emilia Michou,
  • Omar Ortega and
  • Pere Clavé

4 September 2020

(1) Background: The effect of dopaminergic treatment on swallowing response in patients with Parkinson’s disease (PD) suffering oropharyngeal dysphagia (OD) is not understood. Aim: To characterize OD pathophysiology in PD and to assess whether dopami...

  • Review
  • Open Access
71 Citations
16,340 Views
17 Pages

The brain of Drosophila melanogaster is comprised of some 100,000 neurons, 127 and 80 of which are dopaminergic and serotonergic, respectively. Their activity regulates behavioral functions equivalent to those in mammals, e.g., motor activity, reward...

  • Article
  • Open Access
10 Citations
3,506 Views
17 Pages

Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson’s Disease

  • Anna S. Vetchinova,
  • Marina R. Kapkaeva,
  • Mikhail V. Ivanov,
  • Kristina A. Kutukova,
  • Natalia M. Mudzhiri,
  • Lydia E. Frumkina,
  • Anatoly V. Brydun,
  • Vladimir S. Sukhorukov and
  • Sergey N. Illarioshkin

17 October 2023

Parkinson’s disease (PD) is the second most common neurodegenerative disease. Some cases of PD may be caused by genetic factors, among which mutations in the LRRK2 and SNCA genes play an important role. To develop effective neuroprotective stra...

  • Article
  • Open Access
28 Citations
6,019 Views
20 Pages

Synthetic Cathinones Induce Cell Death in Dopaminergic SH-SY5Y Cells via Stimulating Mitochondrial Dysfunction

  • Huey Sze Leong,
  • Morgan Philp,
  • Martin Simone,
  • Paul Kenneth Witting and
  • Shanlin Fu

18 February 2020

Increasing reports of neurological and psychiatric complications due to psychostimulant synthetic cathinones (SCs) have recently raised public concern. However, the precise mechanism of SC toxicity is unclear. This paucity of understanding highlights...

  • Article
  • Open Access
1,236 Views
13 Pages

25 August 2025

Background: Obesity is a complex disorder with both metabolic and neurocognitive consequences, including impairments in prefrontal cortex (PFC)-dependent learning and memory. Combination pharmacotherapy may offer a more effective approach for address...

  • Article
  • Open Access
14 Citations
3,510 Views
17 Pages

26 October 2022

O-cyclic phytosphingosine-1-phosphate (cPS1P) is a novel and chemically synthesized sphingosine metabolite derived from phytosphingosine-1-phosphate (S1P). This study was undertaken to unveil the potential neuroprotective effects of cPS1P on two diff...

  • Article
  • Open Access
643 Views
20 Pages

2 December 2025

With the increasing global burden of major depressive disorder (MDD), identifying modifiable environmental risk factors has become a critical priority. Per- and polyfluoroalkyl substances (PFASs), characterized by environmental persistence and bioacc...

  • Review
  • Open Access
56 Citations
8,724 Views
9 Pages

Mitochondria and α-Synuclein: Friends or Foes in the Pathogenesis of Parkinson’s Disease?

  • Gaia Faustini,
  • Federica Bono,
  • Alessandra Valerio,
  • Marina Pizzi,
  • PierFranco Spano and
  • Arianna Bellucci

8 December 2017

Parkinson’s disease (PD) is a movement disorder characterized by dopaminergic nigrostriatal neuron degeneration and the formation of Lewy bodies (LB), pathological inclusions containing fibrils that are mainly composed of α-synuclein. Dopaminergic ne...

  • Case Report
  • Open Access
7 Citations
789 Views
3 Pages

2 November 2016

Parkinson’s disease (PD) is frequently associated with vasomotor symptoms such as distal cold limbs or sensitivity to cold. Coldness of the lower limbs (COL) usually occurs in winter and is often accompanied by pain, potentially causing difficulty in...

  • Article
  • Open Access
2 Citations
3,357 Views
14 Pages

Sleep Fosters Odor Recognition in Children with Attention Deficit Hyperactivity Disorder but Not in Typically Developing Children

  • Manuel Munz,
  • Christian Dirk Wiesner,
  • Meike Vollersen-Krekiehn,
  • Lioba Baving and
  • Alexander Prehn-Kristensen

2 September 2022

Prior experience represents a prerequisite for memory consolidation across various memory systems. In the context of olfaction, sleep was found to enhance the consolidation of odors in adults but not in typically developing children (TDC), likely due...

  • Article
  • Open Access
1,477 Views
23 Pages

Integrated Behavioral and Proteomic Characterization of MPP+-Induced Early Neurodegeneration and Parkinsonism in Zebrafish Larvae

  • Adolfo Luis Almeida Maleski,
  • Felipe Assumpção da Cunha e Silva,
  • Marcela Bermudez Echeverry and
  • Carlos Alberto-Silva

Zebrafish (Danio rerio) combine accessible behavioral phenotypes with conserved neurochemical pathways and molecular features of vertebrate brain function, positioning them as a powerful model for investigating early neurodegenerative processes and s...

  • Feature Paper
  • Review
  • Open Access
14 Citations
6,908 Views
45 Pages

Neurochemical Features of Rem Sleep Behaviour Disorder

  • Félix Javier Jiménez-Jiménez,
  • Hortensia Alonso-Navarro,
  • Elena García-Martín and
  • José A. G. Agúndez

31 August 2021

Dopaminergic deficiency, shown by many studies using functional neuroimaging with Single Photon Emission Computerized Tomography (SPECT) and Positron Emission Tomography (PET), is the most consistent neurochemical feature of rapid eye movement (REM)...

  • Review
  • Open Access
11 Citations
7,666 Views
21 Pages

Current Treatment Options for REM Sleep Behaviour Disorder

  • Félix Javier Jiménez-Jiménez,
  • Hortensia Alonso-Navarro,
  • Elena García-Martín and
  • José A. G. Agúndez

14 November 2021

The symptomatic treatment of REM sleep behaviour disorder (RBD) is very important to prevent sleep-related falls and/or injuries. Though clonazepam and melatonin are usually considered the first-line symptomatic therapy for RBD, their efficiency has...

  • Article
  • Open Access
5 Citations
4,756 Views
15 Pages

Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse

  • Maria Regoni,
  • Letizia Zanetti,
  • Stefano Comai,
  • Daniela Mercatelli,
  • Salvatore Novello,
  • Federica Albanese,
  • Laura Croci,
  • Gian Giacomo Consalez,
  • Andrea Ciammola and
  • Jenny Sassone
  • + 2 authors

Mutations in the PARK2 gene encoding the protein parkin cause autosomal recessive juvenile parkinsonism (ARJP), a neurodegenerative disease characterized by early dysfunction and loss of dopamine (DA) neurons in the substantia nigra pars compacta (SN...

  • Article
  • Open Access
59 Citations
4,895 Views
14 Pages

Chronic neuroinflammation has been considered to be involved in the progressive dopaminergic neurodegeneration in Parkinson’s disease (PD). However, the mechanisms remain unknown. Accumulating evidence indicated a key role of the blood–br...

  • Review
  • Open Access
59 Citations
4,998 Views
22 Pages

Pathophysiological Features of Nigral Dopaminergic Neurons in Animal Models of Parkinson’s Disease

  • Ezia Guatteo,
  • Nicola Berretta,
  • Vincenzo Monda,
  • Ada Ledonne and
  • Nicola Biagio Mercuri

The degeneration of nigral dopaminergic neurons is considered the hallmark of Parkinson’s disease (PD), and it is triggered by different factors, including mitochondrial dysfunction, Lewy body accumulation, neuroinflammation, excitotoxicity and...

  • Review
  • Open Access
9 Citations
4,352 Views
24 Pages

28 September 2023

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders. The management of PD is a challenging aspect for general physicians and neurologists. It is characterized by the progressive loss of dopaminergic neurons. Impaired...

  • Article
  • Open Access
44 Citations
5,137 Views
13 Pages

Peiminine Protects Dopaminergic Neurons from Inflammation-Induced Cell Death by Inhibiting the ERK1/2 and NF-κB Signalling Pathways

  • Guangxin Chen,
  • Juxiong Liu,
  • Liqiang Jiang,
  • Xin Ran,
  • Dewei He,
  • Yuhang Li,
  • Bingxu Huang,
  • Wei Wang,
  • Dianfeng Liu and
  • Shoupeng Fu

Neuroinflammation, characterized marked by microglial activation, plays a very important role in the pathogenesis of Parkinson’s disease (PD). Upon activation, pro-inflammatory mediators are produced by microglia, triggering excessive inflammatory re...

  • Article
  • Open Access
1,467 Views
16 Pages

The Retinal Dopaminergic Circuit as a Biomarker for Huntington’s and Alzheimer’s Diseases

  • Pedro Blanco-Hernán,
  • Lorena Aguado,
  • María José Asensio,
  • Ana Gómez-Soria,
  • Pedro de la Villa,
  • María José Casarejos and
  • Alicia Mansilla

Retinal dysfunction is emerging as a potential early marker of neurodegenerative diseases. Within the retina, the dopaminergic circuit, comprising dopaminergic amacrine cells, dopamine synthesis and turnover, and dopamine receptor signalling, is esse...

  • Review
  • Open Access
25 Citations
8,155 Views
19 Pages

Hallmarks and Molecular Tools for the Study of Mitophagy in Parkinson’s Disease

  • Thomas Goiran,
  • Mohamed A. Eldeeb,
  • Cornelia E. Zorca and
  • Edward A. Fon

2 July 2022

The best-known hallmarks of Parkinson’s disease (PD) are the motor deficits that result from the degeneration of dopaminergic neurons in the substantia nigra. Dopaminergic neurons are thought to be particularly susceptible to mitochondrial dysf...

  • Review
  • Open Access
42 Citations
13,244 Views
16 Pages

Dopamine Receptors and the Kidney: An Overview of Health- and Pharmacological-Targeted Implications

  • Alejandro Olivares-Hernández,
  • Luis Figuero-Pérez,
  • Juan Jesus Cruz-Hernandez,
  • Rogelio González Sarmiento,
  • Ricardo Usategui-Martin and
  • José Pablo Miramontes-González

10 February 2021

The dopaminergic system can adapt to the different physiological or pathological situations to which the kidneys are subjected throughout life, maintaining homeostasis of natriuresis, extracellular volume, and blood pressure levels. The role of renal...

  • Article
  • Open Access
77 Citations
7,555 Views
12 Pages

Vanillin Protects Dopaminergic Neurons against Inflammation-Mediated Cell Death by Inhibiting ERK1/2, P38 and the NF-κB Signaling Pathway

  • Xuan Yan,
  • Dian-Feng Liu,
  • Xiang-Yang Zhang,
  • Dong Liu,
  • Shi-Yao Xu,
  • Guang-Xin Chen,
  • Bing-Xu Huang,
  • Wen-Zhi Ren,
  • Wei Wang and
  • Ju-Xiong Liu
  • + 1 author

12 February 2017

Neuroinflammation plays a very important role in the pathogenesis of Parkinson’s disease (PD). After activation, microglia produce pro-inflammatory mediators that damage surrounding neurons. Consequently, the inhibition of microglial activation might...

  • Review
  • Open Access
49 Citations
10,138 Views
20 Pages

11 April 2019

Parkinson’s disease (PD) is a neurodegenerative disorder caused by the loss of dopaminergic neurons, leading to the motor dysfunctions of patients. Although the etiology of PD is still unclear, the death of dopaminergic neurons during PD progre...

  • Article
  • Open Access
5 Citations
1,459 Views
17 Pages

Exploring the Role of Ferroptosis in the Pathophysiology and Circadian Regulation of Restless Legs Syndrome

  • Maria Paola Mogavero,
  • Giovanna Marchese,
  • Giovanna Maria Ventola,
  • Giuseppe Lanza,
  • Oliviero Bruni,
  • Luigi Ferini-Strambi and
  • Raffaele Ferri

18 August 2025

The study objectives were to investigate the role of ferroptosis, the mechanism linking iron accumulation, oxidative stress, and dopaminergic dysfunction, in restless legs syndrome (RLS), and to explore its connection with circadian regulation, a key...

  • Article
  • Open Access
156 Citations
15,366 Views
22 Pages

Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy

  • Tsu-Kung Lin,
  • Shang-Der Chen,
  • Yao-Chung Chuang,
  • Hung-Yu Lin,
  • Chi-Ren Huang,
  • Jiin-Haur Chuang,
  • Pei-Wen Wang,
  • Sheng-Teng Huang,
  • Mao-Meng Tiao and
  • Chia-Wei Liou
  • + 1 author

22 January 2014

Parkinson disease (PD) is a complex neurodegenerative disorder characterized by a progressive loss of dopaminergic neurons. Mitochondrial dysfunction, oxidative stress or protein misfolding and aggregation may underlie this process. Autophagy is an i...

  • Article
  • Open Access
10 Citations
3,546 Views
16 Pages

An Early Disturbance in Serotonergic Neurotransmission Contributes to the Onset of Parkinsonian Phenotypes in Drosophila melanogaster

  • Rafaella V. Zárate,
  • Sergio Hidalgo,
  • Nicole Navarro,
  • Daniela Molina-Mateo,
  • Duxan Arancibia,
  • Francisca Rojo-Cortés,
  • Carlos Oliva,
  • María Estela Andrés,
  • Pedro Zamorano and
  • Jorge M. Campusano

5 May 2022

Parkinson’s disease (PD) is a neurodegenerative disease characterized by motor symptoms and dopaminergic cell loss. A pre-symptomatic phase characterized by non-motor symptoms precedes the onset of motor alterations. Two recent PET studies in h...

  • Article
  • Open Access
15 Citations
3,705 Views
13 Pages

Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice

  • Rossana Di Martino,
  • Maria Josè Sisalli,
  • Rossana Sirabella,
  • Salvatore Della Notte,
  • Domenica Borzacchiello,
  • Antonio Feliciello,
  • Lucio Annunziato and
  • Antonella Scorziello

The exact mechanism underlying selective dopaminergic neurodegeneration is not completely understood. The complex interplay among toxic alpha-synuclein aggregates, oxidative stress, altered intracellular Ca2+-homeostasis, mitochondrial dysfunction an...

  • Article
  • Open Access
4 Citations
2,095 Views
18 Pages

Adenosine A2A Receptor Blockade Provides More Effective Benefits at the Onset Rather than after Overt Neurodegeneration in a Rat Model of Parkinson’s Disease

  • Ana Carla L. Nunes,
  • Marta Carmo,
  • Andrea Behrenswerth,
  • Paula M. Canas,
  • Paula Agostinho and
  • Rodrigo A. Cunha

Adenosine A2A receptor (A2AR) antagonists are the leading nondopaminergic therapy to manage Parkinson’s disease (PD) since they afford both motor benefits and neuroprotection. PD begins with a synaptic dysfunction and damage in the striatum evo...

  • Review
  • Open Access
23 Citations
5,314 Views
15 Pages

Neuroprotection against Aminochrome Neurotoxicity: Glutathione Transferase M2-2 and DT-Diaphorase

  • Juan Segura-Aguilar,
  • Patricia Muñoz,
  • Jose Inzunza,
  • Mukesh Varshney,
  • Ivan Nalvarte and
  • Bengt Mannervik

31 January 2022

Glutathione is an important antioxidant that plays a crucial role in the cellular protection against oxidative stress and detoxification of electrophilic mutagens, and carcinogens. Glutathione transferases are enzymes catalyzing glutathione-dependent...

  • Article
  • Open Access
1,639 Views
19 Pages

29 July 2025

Mitochondrial dysfunction is a key contributor to neurodegeneration, particularly in Parkinson’s disease (PD), where dopaminergic neurons being highly metabolically active are vulnerable to oxidative stress and bioenergetic failure. In this stu...

  • Review
  • Open Access
24 Citations
8,127 Views
19 Pages

Molecular Regulation in Dopaminergic Neuron Development. Cues to Unveil Molecular Pathogenesis and Pharmacological Targets of Neurodegeneration

  • Floriana Volpicelli,
  • Carla Perrone-Capano,
  • Gian Carlo Bellenchi,
  • Luca Colucci-D’Amato and
  • Umberto di Porzio

The relatively few dopaminergic neurons in the mammalian brain are mostly located in the midbrain and regulate many important neural functions, including motor integration, cognition, emotive behaviors and reward. Therefore, alteration of their funct...

  • Article
  • Open Access
8 Citations
3,995 Views
12 Pages

25 March 2022

Omega-3 long-chain polyunsaturated fatty acids (n-3 LCPUFA) are critical for cell membrane structure and function. Human beings have a limited ability to synthesise docosahexaenoic acid (DHA), the main n-3 LCPUFA required for neurological development...

  • Feature Paper
  • Review
  • Open Access
16 Citations
6,651 Views
21 Pages

Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease

  • Emilia Pascale,
  • Giuseppina Divisato,
  • Renata Palladino,
  • Margherita Auriemma,
  • Edward Faustine Ngalya and
  • Massimiliano Caiazzo

3 September 2020

Midbrain dopamine neurons have crucial functions in motor and emotional control and their degeneration leads to several neurological dysfunctions such as Parkinson’s disease, addiction, depression, schizophrenia, and others. Despite advances in...

  • Article
  • Open Access
67 Citations
9,378 Views
18 Pages

13 July 2012

Parkinson’s disease (PD) is a progressive neurological disorder marked by nigrostriatal dopaminergic degeneration. Evidence suggests that mitochondrial dysfunction may be linked to PD through a variety of different pathways, including free-radical ge...

  • Review
  • Open Access
71 Citations
15,747 Views
17 Pages

29 October 2020

Parkinson disease (PD) is a neurological movement disorder resulting primarily from damage to and degeneration of the nigrostriatal dopaminergic pathway. The pathway consists of neural populations in the substantia nigra that project to the striatum...

  • Article
  • Open Access
14 Citations
5,180 Views
20 Pages

Targeting Neuroinflammation with Abscisic Acid Reduces Pain Sensitivity in Females and Hyperactivity in Males of an ADHD Mice Model

  • María Meseguer-Beltrán,
  • Sandra Sánchez-Sarasúa,
  • Marc Landry,
  • Nora Kerekes and
  • Ana María Sánchez-Pérez

31 January 2023

Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental syndrome characterized by dopaminergic dysfunction. In this study, we aimed to demonstrate that there is a link between dopaminergic deficit and neuroinflammation that underlies...

of 9